International Stem Cell CorpInternational Stem Cell Corp - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The Sustainability assessment for International Stem Cell Corp represents its transparency towards the UN Sustainable Development Goals. This analysis of International Stem Cell Corp leverages data from across the internet as well as from public documents by International Stem Cell Corp. Other corporations in the scoring industry group for International Stem Cell Corp are displayedin the table.

International Stem Cell Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 8.0, social score of 4.8 and governance score of 2.7.

SDG Transparency Score for International Stem Cell Corp 
Low
0 - 3

5.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for International Stem Cell Corp 
8.0

Environmental

4.8

Social

2.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
912Vivanza Biosciences Ltd
5.3
High
912ValiRx PLC
5.3
High
958International Stem Cell Corp
5.2
High
958Altimmune Inc
5.2
High
958Agios Pharmaceuticals Inc
5.2
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does International Stem Cell Corp have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose current and historical energy intensity?

LockedSign up for free to unlock

Does International Stem Cell Corp report the average age of the workforce?

LockedSign up for free to unlock

Does International Stem Cell Corp reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose cybersecurity risks?

LockedSign up for free to unlock

Does International Stem Cell Corp offer flexible work?

LockedSign up for free to unlock

Does International Stem Cell Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does International Stem Cell Corp conduct supply chain audits?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does International Stem Cell Corp conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose water use targets?

LockedSign up for free to unlock

Does International Stem Cell Corp have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did International Stem Cell Corp have a product recall in the last two years?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose incidents of discrimination?

LockedSign up for free to unlock

Does International Stem Cell Corp allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has International Stem Cell Corp issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose parental leave metrics?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does International Stem Cell Corp support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does International Stem Cell Corp reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is International Stem Cell Corp involved in embryonic stem cell research?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose its waste policy?

LockedSign up for free to unlock

Does International Stem Cell Corp report according to TCFD requirements?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose energy use targets?

LockedSign up for free to unlock

Does International Stem Cell Corp disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does International Stem Cell Corp have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for International Stem Cell Corp
These potential risks are based on the size, segment and geographies of the company.

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.

Sorry!

Failed to process!